Haes et al. realized an LSPR biosensor for the determination of biomarker of Alzheimer's disease by measuring the interactions between amyloid-derived diffusible ligands (ADDL) and the anti-ADDL antibody, involved in Alzheimer's disease. This evidence concerns the gene ADD3 and early-onset autosomal dominant Alzheimer disease.